IP Verse

Prosensa competitive analysis

Latest patents of Prosensa opposed by its competitors

Explore Prosensa's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 27, 2026
Patent NumberPublication DateTitleTotal Oppositions
EP2806900
Dec 15, 2021Rna Modulating Oligonucleotides With Improved Characteristics For The Treatment Of Duchenne And Becker Muscular Dystrophy2
EP2344637
Feb 28, 2018Methods And Means For Efficient Skipping Of Exon 45 In Duchenne Muscular Dystrophy Pre-Mrna1
EP2607484
Jan 6, 2016Methods And Means For Efficient Skipping Of Exon 45 In Duchenne Muscular Dystrophy Pre-Mrna1
EP2203173
Dec 23, 2015Means And Methods For Counteracting Muscle Disorders1

Latest PTAB cases involving Prosensa

Discover the latest PTAB cases involving Prosensa, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Prosensa with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Aug 27, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
PROSENSA - 5 - -
HOWARD WRIGHT NICHOLAS WALLIN WITHERS & ROGERS1 - - -
JAMES POOLE204 - - -
STRAWMAN468 - - -